Skip to content

Doximity DOCS Additional Paid-In Capital

Additional Paid-In Capital at other companies

Veeva Systems logo
Veeva SystemsVEEV
$2.7B+7.2%
Solventum logo
SolventumSOLV
$3.9B+3.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$1.96B+4.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$536.3M-1.7%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$1.7B+90.5%
Cognizant logo
CognizantCTSH
$17M-10.5%

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's additional paid-in capital?
Doximity (DOCS) reported additional paid-in capital of $1B in Q1 2026.
How has Doximity's additional paid-in capital changed year-over-year?
Doximity's additional paid-in capital increased by 12.0% year-over-year, from $894.23M to $1B.
What is the long-term trend for Doximity's additional paid-in capital?
Over 5 years (2021 to 2026), Doximity's additional paid-in capital has grown at a 101.2% compound annual growth rate (CAGR), from $30.36M to $1B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.